Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?
Elizabeth G. Mietlicki‐Baase
Neuropharmacology (2017) Vol. 136, pp. 287-297
Open Access | Times Cited: 25

Showing 25 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 683
Fundamentals on the molecular mechanism of action of antimicrobial peptides
Jessica Audrey Feijó Corrêa, Alberto Gonçalves Evangelista, Tiago de Melo Nazareth, et al.
Materialia (2019) Vol. 8, pp. 100494-100494
Closed Access | Times Cited: 98
Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies
Jéssica Diniz Pereira, Vanêssa Gomes Fraga, Anna Luiza Morais Santos, et al.
Journal of Neurochemistry (2020) Vol. 156, Iss. 6, pp. 753-776
Open Access | Times Cited: 71
Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
Ana Raimundo, Sofia Ferreira, Ivo C. Martins, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 62
Mediators of Amylin Action in Metabolic Control
Christina N. Boyle, Yi Zheng, Thomas A. Lutz
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2207-2207
Open Access | Times Cited: 33
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis
Erwin Lemche, Richard Killick, Jackie Mitchell, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106485-106485
Open Access | Times Cited: 7
High-Speed Atomic Force Microscopy Reveals the Structural Dynamics of the Amyloid-β and Amylin Aggregation Pathways
Takahiro Watanabe‐Nakayama, Bikash R. Sahoo, Ayyalusamy Ramamoorthy, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4287-4287
Open Access | Times Cited: 33
Herpes Zoster virus infection and the risk of developing dementia: A systematic review and meta-analysis
Rowan H. Elhalag, Karam R. Motawea, Nesreen Elsayed Talat, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e34503-e34503
Open Access | Times Cited: 11
Current amyloid inhibitors: therapeutic applications and nanomaterial-based innovations
Paula López-García, María M. Tejero-Ojeda, Marisela Morales, et al.
Progress in Neurobiology (2025), pp. 102734-102734
Closed Access
Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer’s Disease
Ignazio S. Piras, Danielle Brokaw, Yinfei Kong, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 5, pp. 2289-2307
Open Access | Times Cited: 9
Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer's disease
Hana Na, Qini Gan, Liam Mcparland, et al.
Neuropharmacology (2020) Vol. 168, pp. 108017-108017
Open Access | Times Cited: 20
Fremanezumab for the preventive treatment of migraine in adults
Luana Lionetto, Martina Curto, Giusy Ylenia Cisale, et al.
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 741-748
Closed Access | Times Cited: 16
Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer’s Disease
Rachel Corrigan, Luis Labrador, John Grizzanti, et al.
Journal of Alzheimer s Disease (2023) Vol. 91, Iss. 4, pp. 1495-1514
Closed Access | Times Cited: 5
Phytoconstituents of Ashwagandha as potential inhibitors of human islet amyloid polypeptide (hIAPP): an in silico investigation
Nandeshwar, Janmejaya Rout, Smita Manjari Panda, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 11020-11036
Closed Access | Times Cited: 5
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
Som Singh, Felix Yang, Andy Sivils, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 996-996
Open Access | Times Cited: 7
Common Pathological Mechanisms and Risk Factors for Alzheimer’s Disease and Type-2 Diabetes: Focus on Inflammation
Emmanuel Moyse, Mohamed Haddad, Camélia Benlabiod, et al.
Current Alzheimer Research (2019) Vol. 16, Iss. 11, pp. 986-1006
Closed Access | Times Cited: 9
Simultaneous Detection of Tyrosine and Structure‐Specific Intrinsic Fluorescence in the Fibrillation of Alzheimer's Associated Peptides
Anurag Singh, Suparna Khatun, Amar Nath Gupta
ChemPhysChem (2020) Vol. 21, Iss. 23, pp. 2585-2598
Closed Access | Times Cited: 9
The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation
Ying-Ying Yang, Yan-Tao Ren, Meng‐Yu Jia, et al.
Experimental Neurology (2023) Vol. 362, pp. 114346-114346
Closed Access | Times Cited: 3
Involvement of amylin B-H2S-connexin 43 signaling pathway in vascular dysfunction and enhanced ischemia–reperfusion-induced myocardial injury in diabetic rats
Xiaoyong Liu, Yang Rui, Wenwei Bai, et al.
Bioscience Reports (2020) Vol. 40, Iss. 6
Open Access | Times Cited: 7
Is the activity of CGRP and Adrenomedullin regulated by RAMP (−2) and (−3) in Trypanosomatidae? An in-silico approach
Anthony Febres, Oriana Vanegas, Michelle Giammarresi, et al.
Infection Genetics and Evolution (2018) Vol. 61, pp. 197-206
Closed Access | Times Cited: 5
Diabetes/Dementia in Sub-Saharian Africa and Nigerian Women in the Eye of Storm
EK Oghagbon, José Prieto-Pino, Faeren Dogoh, et al.
Current Alzheimer Research (2021) Vol. 19, Iss. 2, pp. 161-170
Closed Access | Times Cited: 2
The Effect of Nutrients on Alzheimer’s Disease Biomarkers: A Metabolomic Approach
Εfstathia G. Kalli
Advances in experimental medicine and biology (2021), pp. 301-308
Closed Access | Times Cited: 2
PHYSIOLOGICAL CHARACTERISTICS OF THE PANCREATIC HORMONE AMILINE AS AN ENDOGENOUS REGULATORY FACTOR
Yu. P. Luts, H. V. Lukyantseva, В. А. Пастухова, et al.
Bulletin of Problems Biology and Medicine (2021) Vol. 1, Iss. 1, pp. 287-287
Open Access
Transcriptome Meta-Analysis Suggests the Existence of Two Molecular Subtypes in Alzheimer’s Disease
Anahita Nazari, Sayed‐Amir Marashi, Hesam Montazeri
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top